| Application no. and date | 02778822.3 (espacenet) (Federated) (European Patent Register), 20021107 | | Patent/reg. no. and date | DK/EP 1467744, 20100915 | | Publication date | 20041020 | | Priority no. and date | US 33835, 20011224 | | EP pub. no. and date |
EP 1467744 20041020 | | Effective date | | | Applicant/owner | Dow Pharmaceutical Sciences, 1330A Redwood Way
Petaluma, CA 94954-6542, US | | Applicant ref. no. | P004734EPDK1 | | Inventor | DOW, Gordon, J., 4189 Chaparral Court
Santa Rosa, CA 95409, US,
CHANG, Yunik, 21234 Via Colombard,
Sonoma, CA 95476, US | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/4174 (2006.01) , A61K 31/455 (2006.01) , A61K 31/724 (2006.01) | | Title | Vandige opløsninger indeholdende metronidazol | | Int. application no. | US2002036063 | | Int. publication no. | WO2003057135 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
